The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Jones Day

Cristiana Spontoni

Tel:
Work +32.2.645.14.48
Email:
Jones Day

Work Department

Health Care; Life Sciences; Digital Health & HIT; Government Regulation

Position

Cristiana Spontoni is internationally recognized as a leader in EU life sciences matters, including EU biotechnology, pharmaceuticals, medical devices, food and cosmetics, as well as in general EU product regulation. Cristiana has advised a number of life sciences clients from the pre-market phase, including clinical trials and pre-market authorizations, to post-market issues, including product liability, marketing and advertising, wholesale distribution, and compliance (including sector specific antibribery and data privacy).She is also actively involved in the shaping of EU legislation affecting the sector and has successfully represented clients in challenging national regulatory developments that were incompatible with EU law. In the chemicals sector, she has advised many clients with respect to REACH and biocides legislation. Cristiana has extensive regulatory experience and routinely handles safety and compliance issues for a large variety of clients both in the life sciences sector and in the consumer products sector in general, including issues that arise in regard to product regulation, crisis management (such as recalls), regulatory enforcement and media attacks, as well as in marketing/advertising/claims and associated substantiation matters. Cristiana frequently manages and coordinates large international assignments on behalf of clients and provides comprehensive one-stop-shop analysis and solutions for cross-border regulatory issues affecting clients' operations. She has coordinated projects in more than 80 countries worldwide.

Languages

English, French, Italian

Member

Admitted to Belgium (EU List) and Italian Bar.

Education

Collegio Europeo di Parma (LL.M. with distinction 1995); Universita degli Studi di Roma "La Sapienza" (Law Degree summa cum laude 1994)


Belgium

EU regulatory: Pharma, medical devices and biotech

Within: Leading individuals

Cristiana Spontoni - Jones Day

Within: EU regulatory: Pharma, medical devices and biotech

In the words of one client, Jones Day combines 'a first-class legal service' with 'an in-depth understanding of EU regulation'. The practice draws upon the strength of the IP, M&A, antitrust and tax areas in advising clients on a broad spread of life sciences regulatory issues. Recent highlights include advising CVC Capital Partners on its $703m acquisition of Teva Pharmaceutical Industries International (non-US) Women’s Health assets. Group head Cristiana Spontoni is widely acknowledged as a market leader in this area.

[back to top]

Industry focus: Healthcare and life sciences

Within: Industry focus: Healthcare and life sciences

The healthcare and life sciences team at Jones Day is headed by Cristiana Spontoni, who co-heads the firm's practice globally, and counts AbbVie, Cellectis and GE Healthcare as clients. It is particularly known for assisting clients with a range of regulatory, corporate, investment and competition matters. The group acted for Astellas Pharma on its €800m cross-border acquisition of Ogeda, including handling antitrust, life sciences, IP and tax elements. It has also been advising several clients, including Acelity Group, on GDPR compliance.

[back to top]


Back to index

Legal Developments by:
Jones Day

  • US rules regarding offshore accounts

    The Hiring Incentives to Restore Employment Act 2010, enacted on 18 March 2010, imposes a new US withholding tax and reporting regime, known as the Foreign Account Tax Compliance Act (FATCA). The FATCA regime applies generally to payments made after 31 December 2012, except on obligations (to be defined in future guidance) outstanding on 18 March 2012. Substantial effort is required by foreign entities to bring their worldwide operations and policies into compliance with the FATCA rules as of the effective date.

    - Jones Day

Legal Developments in Belgium

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to